8-K current report · filed Nov 5, 2026

LIFECORE BIOMEDICAL, INC. DE (LFCR) 8-K Current Report: November 5, 2026

Item 8.01LFCR overview

Short answer

LIFECORE BIOMEDICAL, INC. DE (LFCR) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 8.01 (Other Events). DOJ and FTC early termination of HSR waiting period effective November 4, 2026, clearing the antitrust condition.

LIFECORE BIOMEDICAL, INC. DE 8-K event analysis

AI summary of each reported item and its exhibits

Item 8.01 · Other Events

  • DOJ and FTC early termination of HSR waiting period effective November 4, 2026, clearing the antitrust condition
  • Merger remains pending, with Company stockholder approval and other closing conditions outstanding
  • Transaction converts Lifecore into a wholly owned Parent subsidiary, subject to completion of the merger
  • CVR payments remain uncertain, potentially reducing realized shareholder value after closing

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other LIFECORE BIOMEDICAL, INC. DE 8-K filings

Get the next LFCR 8-K as it lands

Follow LFCR for push alerts, or ask the research agent what this filing means.